Pharma News

This section covers the managerial aspects in the Pharma industry.

Jazz Pharmaceuticals' Rare Liver Disorder Drug wins U.S. Approval

Thursday, March 31, 2016

The US Food and Drug Administration has cleared Jazz Pharmaceuticals Plc39s drug to treat a rare kind of liver disease making it the first treatment to win US approval for the condition The drug defibrotide targets patients with hepatic venoocclusive disease VOD a condition in which some of the vei..

Natco Pharma Gains on Sale of Non-Core Business in US

Thursday, March 31, 2016

Shares of Natco Pharma were up 4 at Rs 415 on the Bombay Stock Exchange on plans to selloff its noncore business The company in a release said the board of directors at its meeting held on March 30 2016 approved the sale of Save Mart Pharmacy Stores located in USA which is noncore business The Sav..

Decline in Financial Settlements with U.S. Big Pharma

Thursday, March 31, 2016

The amount of money big US pharmaceutical manufacturers have paid to settle charges for violating federal health care laws has declined sharply in recent years prompting a nonprofit watchdog group to call for an increase in enforcement efforts In a new analysis that chronicles 25 years worth of pha..

Galmed Pharma Data Demonstrates Significant Reduction of Inflammation

Thursday, March 31, 2016

Galmed Pharmaceuticals PreClinical data demonstrating significant antifibrotic activity of Aramchol in Methionine and choline deficient diet in mice Studies showed both statistically significant reduction of inflammation and statically significant effect on liver fibrosis Source reuterscom ..

Sun Pharma to Buy Japanese Brands From Novartis in $293 Million Deal

Wednesday, March 30, 2016

Sun Pharmaceutical Industries Ltd said it had agreed to buy 14 prescription brands from Novartis AG in a 293 million cash deal that would expand the Indian companys footprint into Japan This acquisition marks Sun Pharmas foray into the Japanese prescription market and provides us an opportunity to ..

PeptiDream Announces Research Collaboration with Asahi Kasei Pharma

Wednesday, March 30, 2016

PeptiDream Inc a public Tokyobased biopharmaceutical company announced today that it has entered into a multitarget discovery and development collaboration with Tokyobased Asahi Kasei Pharma CorpAsahi Kasei Pharma a division of Asahi Kasei Corp TSE First Section 3407 PeptiDream will use its propriet..

FDA Panel Backs Acadia Drug for Psychosis Linked to Parkinson's

Wednesday, March 30, 2016

An advisory panel to the US Food and Drug Administration backed an approval for Acadia Pharmaceuticals Inc39s drug for psychosis related to Parkinson39s disease Nuplazid39s benefits outweighed the risks the panel said after 12 members voted in favor of the treatment and two against Acadia39s share..

Adamis Pharmaceuticals to Acquire US Compounding

Wednesday, March 30, 2016

Adamis pharmaceuticals announces agreement to acquire us compounding Agreement usc will become a whollyowned subsidiary of adamis All of outstanding shares of usc will be converted into right to receive approximately 162 million shares of adamis common stock Under terms of agreement adamis will as..

Novo Nordisk Breaks Ground on USD 2bn Production Facility in Clayton, North Carolina

Tuesday, March 29, 2016

Yesterday Novo Nordisk broke ground on its new 2 billion US dollar production facility in Clayton North Carolina The facility will produce active pharmaceutical ingredients API for a range of Novo Nordisks current and future GLP1 and insulin products Once fully operational in 2020 Clayton will ensu..

U.S. Lawmakers Want Health Agencies to Lower Prostate Cancer Drug Cost

Tuesday, March 29, 2016

A group of lawmakers is calling on the National Institutes of Health and Department of Health and Human Services to step in and reduce the cost of Medivation Inc39s and Astellas Pharma Inc39s prostate cancer drug Xtandi In the letter signed by Democratic US presidential candidate Bernie Sanders and..

U.S. Scientists Develop Mouse Model to Test Zika Vaccines, Drugs

Tuesday, March 29, 2016

US scientists have identified a genetically modified strain of mice that develop Zika an important tool needed for testing vaccines and medicines to treat the virus that is rapidly spreading across the Americas and the Caribbean Early tests on the mice show the virus growing in the testes offering ..

Forge Therapeutics and Active Motif to Collaborate on Epigenetic Research and Drug Discovery

Tuesday, March 29, 2016

Forge Therapeutics Inc a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting metalloproteins and Active Motif a leader in developing tools to enable epigenetics research announced today a research collaboration aimed at advancing epigeneti..

Dr. Reddy’s Laboratories and XenoPort Enter into a U.S. Licensing Agreement for XP23829

Monday, March 28, 2016

Dr Reddy39s Laboratories and XenoPort Inc announced today that they have entered into a license agreement pursuant to which Dr Reddys Laboratories will be granted exclusive US rights for the development and commercialization of XenoPorts clinicalstage oral new chemical entity XP23829 Dr Reddys Labor..

Natco Pharma Slumps After Receiving USFDA Observations for Two Facilities

Monday, March 28, 2016

Natco Pharma slumped 832 to Rs 42940 at 1025 IST on BSE after the company said that it has received 483 observations for two of its manufacturing facilities after an inspection was conducted by the USFDA The announcement was made on Sunday 27 March 2016 Meanwhile the BSE Sensex was down 6562 points..

U.S. spends $3 billion a year on unused cancer drugs

Saturday, March 26, 2016

US doctors and hospitals throw out almost 3 billion roughly 27 billion euros in unused cancer drugs each year because the medicines come in supersized singleuse packages and excess medicine must be discarded for safety reasons a recent paper suggests Researchers focused on 20 expensive medicines th..

FDA Staff backs Acadia's drug to treat psychosis associated with Parkinson's disease

Saturday, March 26, 2016

US Food and Drug Administration staff members said on Friday Acadia Pharmaceuticals Inc39s drug to treat psychosis associated with Parkinson39s disease was effective enough to warrant approval The drug Nuplazid is a new chemical compound and could be the first drug specifically approved in the Unit..

LakePharma Partners with Ampersand, Acquires Blue Sky BioServices

Thursday, March 24, 2016

LakePharma Inc the leading provider of integrated solutions covering the biologics CRO space announces the acquisition of Blue Sky BioServices a CRO specializing in protein and antibody production and assay services The combined company will be known as LakePharma and is now the largest dedicated bi..

Merck Patents on Hepatitis C Treatment Found Valid in Gilead Dispute

Thursday, March 24, 2016

Merck told a federal jury on Tuesday it was seeking more than 2 billion in damages from rival Gilead Sciences after the jury upheld the validity of two Merck patents in a highprofile dispute over Gilead39s blockbuster cure for hepatitis C After returning its verdict in favor of Merck on Tuesday the..

Harbour Group Acquires Pennsylvania Pharmaceutical Packaging Firm, PennTech Machinery Corp

Thursday, March 24, 2016

A portfolio company of Claytonbased Harbour Group has acquired the assets of PennTech Machinery Corp Warminster Pennsylvaniabased SP Industries Inc has purchased PennTech which is based in a Philadelphia suburb for an undisclosed amount PennTech provides pharmaceutical packaging solutions includin..

U.S. FDA Approves Teva's Biotech Drug for Severe Asthma

Thursday, March 24, 2016

The US Food and Drug Administration said on Wednesday it had approved Teva Pharmaceutical Industries Ltd39s drug to treat asthma in adults who have a history of severe attacks despite taking medication The drug Cinqair part of a new wave of biotech drugs for severe asthma is administered intravenou..

TOP